These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12952271)

  • 1. Zardaverine and aerosolised iloprost in a model of acute respiratory failure.
    Schermuly RT; Leuchte H; Ghofrani HA; Weissmann N; Rose F; Kohstall M; Olschewski H; Schudt C; Grimminger F; Seeger W; Walmrath D
    Eur Respir J; 2003 Aug; 22(2):342-7. PubMed ID: 12952271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
    Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
    Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
    J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
    Schermuly RT; Krupnik E; Tenor H; Schudt C; Weissmann N; Rose F; Grimminger F; Seeger W; Walmrath D; Ghofrani HA
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1694-700. PubMed ID: 11719312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
    Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
    Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
    Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
    Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
    Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
    J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs.
    Schermuly RT; Pullamsetti SS; Breitenbach SC; Weissmann N; Ghofrani HA; Grimminger F; Nilius SM; Schrör K; Kirchrath JM; Seeger W; Rose F
    Respir Res; 2007 Jan; 8(1):4. PubMed ID: 17257398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
    Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
    Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics and vasodilatory effect of nebulized and infused iloprost in experimental pulmonary hypertension: rapid tolerance development.
    Schermuly RT; Schulz A; Ghofrani HA; Breitenbach CS; Weissmann N; Hildebrand M; Kurz J; Grimminger F; Seeger W
    J Aerosol Med; 2006; 19(3):353-63. PubMed ID: 17034310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
    Zwissler B; Kemming G; Habler O; Kleen M; Merkel M; Haller M; Briegel J; Welte M; Peter K
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
    Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Leuchte H; Grimminger F; Seeger W; Walmrath D
    Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1361-8. PubMed ID: 11704531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
    Schermuly RT; Weissmann N; Enke B; Ghofrani HA; Forssmann WG; Grimminger F; Seeger W; Walmrath D
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):219-25. PubMed ID: 11509332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against gas exchange abnormalities by pre-aerosolized PGE1, iloprost and nitroprusside in lung ischemia-reperfusion.
    Löckinger A; Schütte H; Walmrath D; Seeger W; Grimminger F
    Transplantation; 2001 Jan; 71(2):185-93. PubMed ID: 11213057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
    Kleen M; Habler O; Hofstetter C; Pusch R; Mueller M; Welte M; Zwissler B
    Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
    Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
    Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
    Welte M; Zwissler B; Habler O; Kleen M; Messmer K
    Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.